SEC Form 4 · accession 0001140361-18-014265
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian Mueller
Officer — SVP, Corporate Controller
Period of report
Mar 15, 2018
Accepted (ET)
Mar 20, 2018 · 2:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 15, 2018 | F | 309 | $83.57 | D | 12,609 | D | |
| Common Stock | Mar 16, 2018 | F | 346 | $84.10 | D | 12,263 | D | |
| Common StockF1,F2 | Mar 15, 2018 | A | 5,710 | $0.00 | A | 17,973 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy Common Stock)F1,F3 | $83.57 | Mar 15, 2018 | A | 9,120 | A | Mar 15, 2019 | Mar 14, 2028 | Common Stock | 9,120 | 9,120 | D |
Explanation of responses
- F1This transaction, originally due to be reported on Monday, March 19, 2018, is being reported late due to an administrative oversight.
- F2Restricted stock units granted on March 15, 2018. Price not applicable.
- F3Option grant vests 12/48th on March 15, 2019 and 1/48th on the 15th day of each month thereafter.